Treatments Offered

At our centers, we offer a variety of intravenous medications to treat a variety of conditions. Below is a list of medications we currently offer. For more information on a specific medication, simply find your medication and select “about this drug” to reveal detailed descriptions.
infusion
ACTEMRA ®
Download Referral Form
About this drug
ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor inhibitor. ACTEMRA is used to treat adults with moderately to severely active rheumatoid arthritis after at least one other medicine called a disease modifying antirheumatic drug has been used and did not work well.


BENLYSTA®
Download Referral Form
About this drug
BENLYSTA is a prescription medication used to treat adults with active systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines.

     

CIMZIA
Download Referral Form
About this drug

Cimizia is a Tumor Necrosis Factor blocker and is used to lessen the signs and symptoms of moderately to severely active Crohn’s disease in patients who have not been helped enough by usual treatments. Cimizia also treats moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    
CINQAIR
Download Referral Form
About this drug
 CINQAIR is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in people aged 18 years of age and older whose asthma is not controlled with the current asthma medicines. When added to other medicines for asthma, CINQAIR helps prevent severe asthma attacks (exacerbations) and can improve your breathing. Medicines such as CINQAIR reduce blood eosinophils.
   

ENTYVIO ®
Download Referral Form
About this drug

ENTYVIO reduces symptoms caused by flare-ups in adults with moderately to severely active ulcerative colitis or moderately to severe Crohn’s disease when other medicines have not worked well enough or cannot be tolerated. Treatments generally take 30 minutes and are administered approximately every eight weeks.

FABRAZYME ®
Download Referral Form
About this drug

Fabrazyme (agalsidase beta) is intended to replace the missing enzyme in patients with this progressive disease. This website offers information about Fabry disease, Fabrazyme, and treatment with enzyme replacement therapy.

IBANDRONATE SODIUM
Download Referral Form
About this drug

Ibandronate sodium is used to treat osteoporosis in women after menopause. Ibandronate sodium has been proven to help women maintain bone density and reverse bone loss. Intravenous infusion time for Ibandronate sodium is minimal and generally takes 15-30 seconds and must be administered every three months.

INJECTAFER ®
Download Referral Form
About this drug

Injectafer is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, and in adult patients with non-dialysis dependent chronic kidney disease.

IVIg
Download Referral Form
About this drug

Intravenous Immunoglobulin is a solution of highly purified immunoglobulin G, derived from large pools of human plasma that contain antibodies against a broad spectrum of bacterial and viral agents. This solution is delivered intravenously and is used primarily to treat three categories of illnesses: immunodeficiencies, autoimmune neuromuscular disorders, and certain rheumatologic conditions.

KRYSTEXXA ®
Download Referral Form
About this drug

Krystexxa is a uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Treatments generally take two hours and are administered approximately every two weeks.

NUCALA ®
Download Referral Form
About this drug

NUCALA reduces the number of eosinophils in the blood. Eosinophils are a type of white blood cell that are a normal part of the body’s immune system. Too many eosinophils may lead to inflammation in the lungs that can cause severe asthma attacks. NUCALA is given as a single injection by a healthcare provider, just under the skin (subcutaneously), once every four weeks.

NULOJIX ®
Download Referral Form
About this drug

NULOJIX is a prescription medicine used to prevent transplant rejection in adults who have received a kidney transplant. NULOJIX, an intravenous infusion, is used with corticosteroids and certain other medicines. NULOJIX weakens the immune system after a kidney transplant so the body won’t attack the transplanted organ. Treatments generally take 30 minutess and are administered approximately every two weeks.

ORENCIA ®
Download Referral Form
About this drug

Orencia is approved for the treatment of moderate to severe rheumatoid arthritis. While infusion therapy is based on a patient’s body weight, intravenous infusion time generally takes 30 to 60 minutes and is administered at two-and four weeks after the first infusion and then every four weeks following the initial treatment.

OCREVUS ®
Download Referral Form
About this drug

Description to come.

PROLASTIN C ®
Download Referral Form
About this drug

Description to come.

PROLIA ®
Download Referral Form
About this drug

Prolia is a prescription medicine used to treat osteoporosis in women after menopause who are at high risk for fracture, meaning women who have had a fracture related to osteoporosis, who have multiple risk factors for fracture, or cannot use another osteoporosis medicine or other osteoporosis medicines did not work well.

REMICADE ®
Download Referral Form
About this drug

Remicade is a biologic treatment that has been used to treat individuals with a range of conditions such as: plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, adult Crohn’s disease, ulcerative colitis and ankylosing spondylitis. Intravenous infusion time for Remicade is approximately three to four hours.

RITUXAN ®
Download Referral Form
About this drug

Rituxan (Rituximab) is a medication that is used for the treatment of non-hodgkins lymphoma and rheumatoid arthritis. When used in combination with methotrexate, Rituxan is indicated to reduce signs and symptoms of rheumatoid arthritis and to slow the progression of structural damage of this disease in adult patients. Intravenous infusion time varies by patient but generally treatments must be separated by two weeks.

SIMPONI ARIA ®
Download Referral Form
About this drug

SIMPONI ARIA is a biologic infusion treatment for adults with moderate to severe rheumatoid arthritis and is used with methotrexate.

STELARA ®
Download Referral Form
About this drug

Stelara® is a medication for adult patients that is used to treat to psoriatic conditions: moderate or severe plaque psoriasis and active psoriatic arthritis. Stelara® has also been approved by the FDA for the treatment of adult patients with moderately to severe active Crohn’s disease.

TYSABRI ®
Download Referral Form
About this drug

Tysabri is prescribed to treat adults with relapsing forms of multiple sclerosis to slow worsening disability and reduce number of flare-ups.

XOLAIR ®
Download Referral Form
About this drug

Xolair (Omalizumab) Allergic Asthma medication is an injectable prescription allergy medication for patients with moderate to severe persistent allergic asthma caused by year-round allergies. When added to the patient’s current asthma treatment, Xolair has been shown to reduce the number of daytime and nighttime asthma attacks in patients still having two or more asthma attacks a year despite treatment.

ZOLEDRONIC ACID
Download Referral Form
About this drug

Zoledronic acid is the only FDA-approved, once-a-year treatment for postmenopausal osteoporosis. One annual dose, along with daily calcium and vitamin D, helps to increase bone density, protecting and strengthening your bones.